Jul 25, 2022 / 09:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Zymergen Business Update Conference Call. (Operator Instructions)
I would now like to turn the conference to your host, Ms. Carrie Mendivil with Investor Relations. Please go ahead.
Carrie Mendivil -
Thank you. Earlier today, Zymergen issued a joint press release with Ginkgo Bioworks announcing a definitive merger agreement for Ginkgo to acquire Zymergen. Joining me today to discuss this announcement as well as other organizational updates is Jay Flatley, acting Chief Executive Officer of Zymergen.
Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of the federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated.
Additional information regarding these risks and uncertainties appears in the section entitled Forward-Looking Statements in the press release Ginko Bioworks
Ginkgo Bioworks Holdings, Inc., Zymergen Inc. - M&A Call Transcript
Jul 26, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers